Physician profile
Marc Jonathan Stratton
NPI 1386698330
$1,737.46
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $279 · 2021: $33.08.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $320.50 | 2019-2020 | |
| Janssen Biotech, INC. | $281.47 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $203.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.78 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $182.78 | 2019-2020 | |
| Neotract INC. | $117.51 | 2019-2020 | |
| Abbvie INC. | $85.74 | 2019 | |
| Allergan, INC. | $56.53 | 2019 | |
| Blue Earth Diagnostics | $45.93 | 2019 | |
| Boston Scientific Corporation | $36.95 | 2019-2020 | |
| Acerus Pharmaceuticals Corporation | $33.08 | 2021 | |
| Metuchen Pharmaceuticals | $31.74 | 2019 | |
| Endo Pharmaceuticals INC. | $30.72 | 2019-2020 | |
| Pfizer INC. | $27.53 | 2019-2020 | |
| Sagent Pharmaceuticals | $24.14 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $17.91 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $16.86 | 2020 | |
| Ethicon US, LLC | $15.49 | 2019 | |
| Photocure INC | $14.02 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$88,528.10 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Stratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.